16 results
IDSA Recommendations for the Treatment of Clostridium difficile Infection in Adults
Source: https://doi.org/10.1093/cid/cix1085

#Management #Clostridium #CDifficile #IDSA2017 #Guidelines
IDSA Recommendations ... for the Treatment ... Infection in Adults ... cid/cix1085 #Management ... #Clostridium #CDifficile
IDSA 2017 CDiff Guidelines - Table 1. Recommendations for the Treatment of Clostridium difficile Infection in Adults

#Management
IDSA 2017 CDiff ... Recommendations for the Treatment ... Infection in Adults ... #Management # ... Clostridium #CDifficile
IDSA 2017 CDiff Guidelines - Table 2. Recommendations for the Treatment of Clostridium difficile Infection in Children

#Management
IDSA 2017 CDiff ... Recommendations for the Treatment ... Infection in Children ... #Management # ... #Clostridium #CDifficile
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Potential Treatment ... Agents for Treatment ... infection Episode ... #Pharmacology #Management
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Infection (CDI) ... Diagnosis and Management ... Toxic Megacolon, Shock ... can be community-acquired ... Ileus, Megacolon, Shock
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
steroids to treat infectious ... Severe Community Acquired ... Typhoid fever - Bacterial ... #Pharmacology #Management ... #Treatment #Indications
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Enteric Infections ... Treating Clostridium difficile ... #IDSA #Prevention ... #Treatment #management
Causes of Antibiotic Failure - Differential Diagnosis Framework
Diagnosis:
 • Non-Infectious: Malignant, Autoimmune, Drug-related (NMS, serotonin syndrome,
Bug: Atypical bacteria ... Immunocompromise Treatment ... • Secondary to Treatment ... diff) • Hospital-Acquired ... Difficile, COVID
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
Purtilo (XLP) Acquired ... CMV, HHV8,...), Bacteria ... Unknown cause Treatment ... Lymphohistiocytosis #diagnosis #management ... #treatment #summary
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... antifungals are required ... candida #mucosal #IDSA ... #management #opportunistic ... #infections #HIVAIDS